| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2012: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Research Abstract |
We performed a molecular epidemiolygical study of 300 clinical isolates of Pseudomonas aeruginosa in 2011 in Japan. Of them, we found a novel aminoglycoside 6'-N-acetyltransferase gene, aac(6')-Iaj.The encoded protein, AAC(6')-Iaj, was found to consist of 184 amino acids, with 70% identity to AAC(6')-Ia. Escherichia coli transformed with a plasmid containing the aac(6')-Iaj gene acquired resistance to all aminoglycosides tested except gentamicin. Of note, aac(6')-Iaj contributed to the resistance to arbekacin.
In 2012, we found two novel IMP-type metallo-beta-lactamase variants, IMP-43 and IMP-44, which were identified in multidrug-resistant Pseudomonas aeruginosa isolates obtained in medical settings in Japan. These two variants had more efficient catalytic activities against all carbapenems tested, including dripenem, imipenem, meropenem and panipenem.
|
